Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/353278/000117184318007258/f6k_102618.htm
January 2023
January 2023
January 2023
January 2023
December 2022
December 2022
December 2022
December 2022
December 2022
November 2022
Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/353278/000117184318007258/f6k_102618.htm
Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Novo Nordisk A S.
Novo Nordisk A S's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Ticker: NVO
CIK: 353278
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001171843-18-007258
Submitted to the SEC: Fri Oct 26 2018 10:11:21 AM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, October 26, 2018
Industry: Pharmaceutical Preparations